Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on April 30, 2025
Arialief Reviews (DOCTOR INVESTIGATION REVEALS) Natural, Science-Backed Relief for Chronic Pain & Inflammation
GlobeNewswire
·
April 30, 2025
FINDLAY, Ohio, April 30, 2025 (GLOBE NEWSWIRE) -- Introduction: Understanding Nerve Pain and the Promise of Arialief Millions of people worldwide suffer silently from nerve pain — a condition that slowly steals mobility, independence, and quality of life. …
Corporate Update
GlobeNewswire
·
April 30, 2025
Boston, MA, April 30, 2025 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) Vystar received notice of final approval of its Form 15C-211 application. In addition, today the Company moved from the Pink Sheets to the OTCQB Exchange. The Company …
Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness
GlobeNewswire
·
April 30, 2025
MELBOURNE, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTC: FITY), a leader in innovative technology and wellness solutions, is thrilled to announce that Michael Lawson has assumed the roles of Chief Executive Officer and …
AAPA 2025 Salary Report: Rising Compensation Confirms PA Profession’s Vital Role in Healthcare System
GlobeNewswire
·
April 30, 2025
Alexandria, Va., April 30, 2025 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) has released the findings of its 2025 AAPA Salary Report, shedding light on key trends shaping the physician associate/assistant (PA) profession. …
InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference
GlobeNewswire
·
April 30, 2025
MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the Bank of …
Bioma Probiotics Reviews: Best Probiotic For Gut Health & Weight Loss Ingredients & Side Effects
GlobeNewswire
·
April 30, 2025
Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- In the present health-aware world, probiotics have become a pillar for the upkeep of gut health and general well-being. Among the numerous choices out there, Bioma Probiotic is notable for its …
Oncocyte Provides Positive Update on Clinical Trial Progress
GlobeNewswire
·
April 30, 2025
Central Institutional Review Board approved, final preparatory steps underway at first transplant centers Three of the top 10 U.S. transplant centers expected to participate in trial Nearly 10% of annual U.S. transplant volume represented in trial site …
Folia Health and Inspire are Partnering to Bring Personalized Home Health Observations to the Forefront of Patient Focused Drug Development Research
GlobeNewswire
·
April 30, 2025
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- Folia Health, the pioneer of patient-driven Home Reported Outcomes (HRO), has partnered with Inspire, the world's leading online health community and real-world data platform, to uniquely empower patients and …
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7
GlobeNewswire
·
April 30, 2025
DUBLIN, Ireland, April 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:00 a. …
Cidara Therapeutics to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will …
Actinogen provides pivotal Alzheimer’s trial enrolment update and other business news
GlobeNewswire
·
April 30, 2025
SYDNEY, April 30, 2025 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that its Alzheimer’s disease phase 2b/3 trial has now enrolled 60 participants and expects to reach 100 by the end of this quarter. That milestone will trigger an …
Best Testosterone Booster Supplement for Males Over 40: Why TestoPrime Leads for Muscle, Energy & Libido
GlobeNewswire
·
April 30, 2025
New York City, April 30, 2025 (GLOBE NEWSWIRE) -- Introduction: Why Testosterone Support Matters After 40 As men age, maintaining strength, stamina, and masculinity becomes increasingly difficult — and one of the biggest reasons is a steady decline in …
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
GlobeNewswire
·
April 30, 2025
Highlights Reported positive topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) led by robust clinical efficacy Phase 2 data featured in an oral presentation at the American Academy of Neurology …
Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting
GlobeNewswire
·
April 30, 2025
Preclinical data demonstrates unique binding location of CT-95 on mesothelin and avoidance of binding to shed mesothelin Data supports ongoing Phase 1 clinical trial for CT-95 PHILADELPHIA, April 30, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“ …
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, …
EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 30, 2025
WATERTOWN, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today …
Veri Medtech (VRHI) Relaunches Veriheal.com
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Veri Medtech (Stock Ticker Symbol: “VRHI”) announced today that it has relaunched its Veriheal.com healthcare technology platform. For more information, please visit: www.Veriheal.com. “Veri Medtech (VRHI) has …
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 30, 2025
RAMSEY, N.J. and BOCA RATON, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing …
Larimar Therapeutics Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 30, 2025
FDA stated as part of a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval BLA seeking accelerated approval planned to be submitted by year-end …
XORTX Provides Update on FDA Type B Meeting Request
GlobeNewswire
·
April 30, 2025
● XORTX will focus on key steps to advance a NDA filing for Gout indication ● CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical …